Beyond Theory: Real-World AI Wins in Life Science R&D – Faster & Smarter

A series of webinars and events titled 'Beyond Theory:
Real-World AI Wins in Life Science R&D – Faster & Smarter' are taking place in mid-2025, focusing on actionable AI strategies to maintain quality and accelerate development under financial pressure12.

Industry experts will discuss practical AI applications in drug discovery and development, emphasizing how AI is streamlining processes, reducing costs, and expediting research timelines12.

AI is being widely adopted to improve clinical trial efficiency by cutting costs, increasing participant recruitment speeds, and enabling breakthroughs for rare diseases and other areas with limited data5.

Recent advances include AI-driven drug discovery, as demonstrated by Insilico Medicine's AI-designed drug Rentosertib, which recently received generic name approval for rare disease treatment3.

Experts anticipate that by leveraging AI for powerful data analysis even with small datasets, significant innovation in drug development—especially for rare diseases—will be possible in 20255.

Sources:

1. https://www.biospace.com/webinar-beyond-theory

2. https://phoenixbiosciencecore.com/event/beyond-theory-real-world-ai-wins-in-life-science-rd-faster-smarter/

3. https://www.crescendo.ai/news/latest-ai-news-and-updates

5. https://www.drugtargetreview.com/article/154981/how-ai-will-reshape-pharma-by-2025/